EXPLORE THE SCIENCE
TL;DR: A 2026 randomized pilot trial in European Journal of Psychotraumatology found no overall PTSD advantage when refugee-focused emotion-regulation skills training was added before narrative exposure therapy, but refugees living with high visa or family ins…
Read article
TL;DR: A 2026 study in Journal of Pain Research found that spinal cord stimulation and dorsal root entry zone lesioning reduced pain for selected patients with refractory postherpetic neuralgia, but the evidence came from a 10-patient single-center series. Key…
Read article
TL;DR: A 2026 European Journal of Pediatrics study found that children with phenylketonuria, or PKU, had higher depression scores and lower quality of life than controls, with the worse pattern in children diagnosed later. Key Findings Children studied: The st…
Read article
TL;DR: A 2026 Neurological Sciences study followed 216 early Parkinson’s patients for 2 years after levodopa started and found that several non-motor symptom differences between men and women persisted or emerged despite adjustment for baseline scores and levo…
Read article
TL;DR: A 2026 mouse study in Communications Biology found that activating parvalbumin (PV) interneurons, inhibitory nerve cells in the orbitofrontal cortex, reduced default mode network connectivity and decreased normal social approach and sniffing behavior. K…
Read article
TL;DR: A 2026 retrospective ICU study in the International Journal of General Medicine found that 24-hour open visiting was associated with lower delirium incidence and lower anxiety/depression scores than 1-hour restricted visiting in chronic critically ill p…
Read article
TL;DR: A 2026 study in BMC Psychology found high rates of depression, anxiety, and recent self-harm thoughts among international students in Germany, with acculturative stress linked to worse mental health and mindfulness, optimism, self-efficacy, acceptance,…
Read article
TL;DR: A 2026 randomized phase 2b trial in Journal of Clinical Psychopharmacology found that the PDE10A inhibitor MK-8189 did not improve Positive and Negative Syndrome Scale (PANSS) schizophrenia symptom scores more than placebo after 6 weeks, while risperido…
Read article
TL;DR: A 2026 study in Neuropsychopharmacology used CRISPR gene editing in human microglia-like cells and found that several schizophrenia-linked genes changed phagocytosis, cell shape, and immune-transcription programs. Key Findings Schizophrenia-linked micro…
Read article
TL;DR: A 2026 qualitative analysis in PLOS One used 505 ME/CFS memorial entries to map how systemic neglect, clinical dismissal, social isolation, and personal burden appeared in accounts of illness and death. Key Findings 505 memorial entries: The analysis us…
Read article